3Gridelli C,Perrone F,Monfardini S.Lung cancer in the elderly.Eur.J Cancer,1997,33:2313～2314.
4Nakamura Y,Sekine Ⅰ,Furuse K.Retrospective comparison of toxicity and efficacy in phase Ⅱ trails of 3-h infusions of paclitaxel for patients 70 years of age or older and patients under 70 of age.Cancer Chemother.Pharmacol.,2000,46:114～118.
5Martin C.Ardizzoni A.Rosso R.Gemcitabine:safety profile and efficacy in non small cell lung cancer unaffected by age.Aging,1997,9:297～303.
6Furuse K.Gemcitabine in the treatment of non-small cell lung cancer for elderly patients.GanToKagakuRyoho 1999,26:890～897;
7Colleoni M,Gaion F,Nelli P,et al.Weekly vinorelbine in elderly patients with non small cell lung cancer.Tumori,1994,80:448～452.
8Beretta GD,Michetti G,Belometti MO,et al.Gemcitabine plus vinorelbine in elderly or unfit patients with non small cell lung cancer.Br J Cancer,2000,83:573～576.
9Gridelli C,Rossi A,Scognamiglio F,et al.Carboplatin plus oral etoposide in elderly patients with advanced non small cell lung cancer.A phase Ⅱ study.Anticancer Research,1998,17:4755～4758.
10Gridelli C,Cigolari S,Galli L,et al.MILES investigators.Activity and toxicity of gemcitabine and gemcitabine+ vinorelbine in advanced non small cell lung cancer elderly patients:a phase Ⅱ data from Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trail.Lung Cancer,2001,31:277～284.
